About Joel Whitley
Joel Whitley is a director at VenoStent.
Form D filings also name Joel Whitley as a director at Cornelis, Lindy Biosciences and Nlx.
Joel Whitley first appears on SEC filings in 2022.
Experience
This experience comes from Joel Whitley's profile and from SEC filings. For roles taken from filings, the years are when the filings name Joel Whitley in the role, so the role may have started earlier or lasted longer.
VenoStent, Inc. Current
Director
2023 – Present · Houston, TX
Develops an absorbable blood vessel wrap for patients who need hemodialysis.
CI
Coagulo Medical Technologies, Inc. Current
Board Observer
2023 – Present
Cornelis Networks, Inc. Current
Director
2022 – Present · Wayne, PA
Networking hardware and software for AI and high-performance computing systems.
RI
Rellevate, Inc. Current
Board Observer
2022 – Present
CI
CIQ Current
Board Member
2022 – Present
AL
Ayar Labs Current
Board Observer
2022 – Present
IP
IAG Capital Partners Current
Partner
2019 – Present
CR
Creovai
Board Observer
2023 – 2025
SL
Sherman Capital Markets, LLC
Director
2015 – 2019
AS
ASRC Energy Services
Vice President and General Counsel
2013 – 2015
AC
Arctic Slope Regional Corporation
Senior Corporate Counsel
2010 – 2012
ML
Munger, Tolles & Olson LLP
Associate
2005 – 2010
SS
She's Your Sister
Lead Singer and Guitarist
2003 – 2008
Key Colleagues at Startups
The people Joel Whitley works with at each company, as listed on that company's latest Form D.
Cornelis Networks, Inc. · Form D/A, Jul 20, 2026
AG
Alonso Galvan
Director
PJ
Philip Murphy Jr.
Co-Founder, President, and Chief Operating Officer, director
LS
Lisa Spelman
Chief Executive Officer and director
VenoStent, Inc. · Form D, May 1, 2026
Geoffrey Lucks
COO & Co-founder, director
Timothy Boire
CEO & Co-founder, director
JM
Jim Monsor
Director
RC
Robert Crutchfield
Director
Lindy Biosciences, Inc. · Form D, Mar 19, 2024
KL
Karen LeVert
Director
OF
Omar Flores
Executive officer and director
DB
Deborah Bitterfield
CEO and director
NLX Inc. · Form D, Feb 22, 2024